| 2545 |
1847: SARS-CoV-2 production |
1870: Sustentacular cells, decrease |
Jan 5, 2022 |
Jan 5, 2022 |
1 AOP
|
| 2546 |
1847: SARS-CoV-2 production |
1931: Disruption of the intestinal barrier |
Jan 5, 2022 |
Jun 14, 2022 |
1 AOP
|
| 2329 |
1855: Increased Sodium-sensitive hypertension |
1603: Chronic kidney disease |
Apr 10, 2021 |
Apr 10, 2021 |
1 AOP
|
| 2698 |
2033: Increased S1-P |
1502: Histone deacetylase inhibition |
Jul 19, 2022 |
Jul 19, 2022 |
1 AOP
|
| 1592 |
1441: Systemic cholesterol increased |
1442: Foam cell formation |
Jun 29, 2017 |
Jun 29, 2017 |
None
|
| 2315 |
1858: Increased viral transcription and replication |
1496: Increased proinflammatory mediators |
Apr 9, 2021 |
Apr 9, 2021 |
None
|
| 2316 |
1858: Increased viral transcription and replication |
1848: TLR Activation/Dysregulation |
Apr 9, 2021 |
Apr 9, 2021 |
None
|
| 1445 |
1326: Increased, 5-HT3 |
1344: Increased, seizure |
Apr 14, 2017 |
Apr 14, 2017 |
1 AOP
|
| 707 |
708: Increased, Accumulation of alpha2u microglobulin (proximal tubular epithelium) |
709: Increase, Cytotoxicity (renal tubular cell) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 146 |
134: Increased, Activation and Recruitment of Hepatic macrophages (Kupffer Cells) |
209: Peptide Oxidation |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 147 |
134: Increased, Activation and Recruitment of Hepatic macrophages (Kupffer Cells) |
276: Up Regulation, TGFbeta1 expression |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 3236 |
2231: Increased, activation of RAAS |
2230: Increased, afferent artery vasoconstriction |
Jun 6, 2024 |
Jun 6, 2024 |
None
|
| 1706 |
1499: Activation of Th2 cells |
1500: Increased cellular proliferation and differentiation |
Jan 5, 2018 |
May 18, 2023 |
1 AOP
|
| 1073 |
1029: Increased, adipogenesis |
1032: Increased, secretion of local growth factors |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 3235 |
2230: Increased, afferent artery vasoconstriction |
819: Decreased, Glomerular filtration |
Jun 6, 2024 |
Jun 6, 2024 |
1 AOP
|
| 3255 |
2241: Increased, AP-1 activity |
2242: Increased, edn1 gene expression |
Jun 20, 2024 |
Jun 20, 2024 |
1 AOP
|
| 568 |
574: Increased, Appetite and hunger |
560: Abnormal, Foraging activity and behavior |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 607 |
602: Increased, Ataxia, paralysis, or hyperactivity |
351: Increased Mortality |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 432 |
444: Increased, Atrioventricular block and bradycardia |
351: Increased Mortality |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 591 |
444: Increased, Atrioventricular block and bradycardia |
445: Respiratory distress/arrest |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 2871 |
2124: increased, Bax |
55: Cell injury/death |
Apr 4, 2023 |
Apr 4, 2023 |
1 AOP
|
| 2874 |
2124: increased, Bax |
1825: Increase, Cell death |
Apr 4, 2023 |
Apr 4, 2023 |
None
|
| 706 |
714: Increased, Binding of chemicals to 2u (serum) |
708: Increased, Accumulation of alpha2u microglobulin (proximal tubular epithelium) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1135 |
1098: Increased, blood potassium concentration |
1100: Occurrence, cardiac arrthymia |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1140 |
1098: Increased, blood potassium concentration |
1106: Occurrence, cardiac arrhythmia |
Nov 29, 2016 |
Dec 3, 2016 |
3 AOPs
|